We can confirm these results in our cellular models because we observed that the kinetics of activation of the Ca2+ response obtained in NB-DNJ-treated CF cells do not mimic the effect of the inhibitors of the IP3R and we observed a variation of the ER morphology between non CF or corrected and uncorrected epithelial cells. The gene discussed is ITPR3; the disease is cystic fibrosis.